This article is more than 5 years old. Information may no longer be current.

Integra LifeSciences introduces allograft cancellous sponge

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Integra LifeSciences Holdings Corp. announced today the launch of Integra Allograft Cancellous Sponge, a compressible bone graft composed of 100% cancellous bone.

The sponge-like handling characteristics of Integra Allograft Cancellous Sponge allow it to absorb fluids like saline, blood or bone marrow aspirate. After rehydration, the allograft cancellous sponge can be compressed to half its original size and expands back to conform to a variety of spaces and defects, for maximum surgical flexibility, the company said in a press release.

"The unique handling characteristics and biocompatibility of Integra Allograft Cancellous Sponge make it an ideal addition to Integra's portfolio of allografts and orthobiologics, and provide another flexible solution for improving patient care," Bill Weber, vice president of Integra OrthoBiologics, stated in the release.

The Integra distributor network sells Integra Allograft Cancellous Sponge in the United States. Integra's extensive line of orthobiologic products allows the distributor network to provide a complete range of bone graft substitutes to orthopedic surgeons and neurosurgeons, the company noted.